Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × Exercise × 30 days × Clear all

Sponsor

Conditions

Motor Activity 6 Neoplasms 3 Breast Neoplasms 3 Neoplasm Metastasis 2 Testicular Neoplasms 1 Skin Neoplasms 1 Sarcopenia 1 Recurrence 1 Quality of Life 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Muscular Atrophy 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lymphedema 1 Lung Neoplasms 1 Leukemia 1 Hodgkin Disease 1 Fatigue 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Related Fatigue 1 Breast Cancer Survivors 1 Brain Neoplasms 1 Bone Metabolism Biomarkers 1 Aerobic Exercise 1

Interventions

Gemcitabine 7 Cisplatin 7 durvalumab 6 pembrolizumab 4 Bevacizumab 4 Oxaliplatin 3 Capecitabine 3 lenvatinib 2 S 1 (combination) 2 Leucovorin 2 Injections 2 Folfox protocol 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 zanidatamab 1 trastuzumab deruxtecan 1 gemcitabine-oxaliplatin regimen 1 envafolimab 1 atezolizumab 1 Trastuzumab 1 Tegafur 1 Prednisone 1 Prednisolone 1 Nivolumab 1 Irinotecan 1 Infusions, Intravenous 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Docetaxel 1 CA-4948 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡